Consumer Goods Active Runners: Apple Inc. (NASDAQ:AAPL), General Motors Company (NYSE:GM), Ford Motor (NYSE: F), The Coca-Cola Company (NYSE:KO)

Apple Inc. (NASDAQ: AAPL) is a position that Mr. Icahn has made money in. That said, the only thing that he influenced was an evening of Tim Cook’s time for a dinner. Apple is buying back stock, and the company may boost its dividend again. Mr. Icahn’s position was at 4.7-M/shares, but he said he…

Read More

Basic Material Active Stocks: Petroleo Brasileiro Petrobras (NYSE:PBR), Alcoa Inc (NYSE:AA), Vale (NYSE:VALE), Kinross Gold Corporation (USA) (NYSE:KGC)

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), or Petrobras, is the state-controlled oil and gas giant. Petrobras has burned many investors on the other side of the Americas, largely because its capital structure is set up to take care of common shareholders further down the road – the Brazilian taxpayers (or consumers), its employees and workforce,…

Read More

Biotech Most Volatile: Aastrom Biosciences (NASDAQ:ASTM), CytRx Corporation (NASDAQ:CYTR), Imprimis Pharmaceuticals (NASDAQ:IMMY), Idenix Pharmaceuticals (NASDAQ:IDIX)

Aastrom Biosciences Inc (NASDAQ:ASTM)’s shares declined 19.11% to $5.25. The company announced that Nick Colangelo, President and CEO of Aastrom, will present at the 2014 Regen Med Investor Day on March 26 at 3:15 p.m. EDT at the Metropolitan Club in New York City. Aastrom Biosciences Inc (NASDAQ:ASTM) stock performance was -2.95% in last session…

Read More

Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Akebia Therapeutics Inc. (NASDAQ:AKBA) offered 5.9 million shares in its Thursday IPO at $17 a share, the high end of the stock’s expected price range. Among other therapeutics, the biopharma company is developing a once-daily oral therapy for patients with kidney disease. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock performance was -0.99% in last session and finished…

Read More

Biotech Losers: Inovio Pharmaceuticals (NYSEMKT:INO), Oncomed Pharmaceuticals (NASDAQ:OMED), Enzymotec (NASDAQ:ENZY), Veracyte Inc (NASDAQ:VCYT)

Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) announced financial results for the quarter and year ended December 31, 2013. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -7.98% in last session and finished the day at $3.23. Traded volume was 10,401,414 million shares in the last session and the average volume of the stock remained 7.79 million shares. The…

Read More
FB Nasdaq FB Facebook

Biotech Gainers: Novavax (NASDAQ:NVAX), OXiGENE Inc (NASDAQ:OXGN), Imprimis Pharmaceuticals (NASDAQ:IMMY), Oramed Pharmaceuticals (NASDAQ:ORMP)

Novavax (NASDAQ:NVAX) Director Richard Douglas acquired 50,000 shares of Novavax stock in a transaction that occurred on Tuesday, March 25th. Novavax, Inc. (NASDAQ:NVAX) stock performance was 8.47% in last session and finished the day at $4.48. Traded volume was 7,425,052 million shares in the last session and the average volume of the stock remained 5.05…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓